Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Keratinocytes | 5 | 2004 | 9 | 0.360 |
Why?
|
| Papillomaviridae | 4 | 2005 | 23 | 0.300 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2003 | 62 | 0.270 |
Why?
|
| Secretin | 5 | 2003 | 9 | 0.250 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2002 | 16 | 0.240 |
Why?
|
| Head and Neck Neoplasms | 2 | 2002 | 11 | 0.230 |
Why?
|
| Tumor Virus Infections | 1 | 2002 | 10 | 0.190 |
Why?
|
| Papillomavirus Infections | 1 | 2002 | 22 | 0.190 |
Why?
|
| Transcriptional Activation | 3 | 2007 | 6 | 0.190 |
Why?
|
| Oncogene Proteins, Viral | 3 | 2007 | 7 | 0.170 |
Why?
|
| Transcription Factors | 2 | 2003 | 32 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1999 | 1 | 0.160 |
Why?
|
| Transcription Factor AP-1 | 1 | 1999 | 1 | 0.160 |
Why?
|
| Retinoblastoma Protein | 1 | 1999 | 3 | 0.160 |
Why?
|
| HIV-1 | 3 | 2004 | 17 | 0.160 |
Why?
|
| Gene Expression | 3 | 2003 | 55 | 0.130 |
Why?
|
| Base Sequence | 7 | 2004 | 35 | 0.130 |
Why?
|
| Repressor Proteins | 2 | 2007 | 7 | 0.130 |
Why?
|
| Cells, Cultured | 6 | 2004 | 164 | 0.110 |
Why?
|
| Ethanol | 2 | 2004 | 55 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2003 | 15 | 0.100 |
Why?
|
| Mouth Mucosa | 2 | 2003 | 12 | 0.100 |
Why?
|
| Humans | 13 | 2011 | 4931 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2003 | 23 | 0.100 |
Why?
|
| DNA Replication | 2 | 2002 | 2 | 0.090 |
Why?
|
| Genes, Regulator | 1 | 1991 | 1 | 0.090 |
Why?
|
| Operon | 1 | 1991 | 1 | 0.090 |
Why?
|
| Rhamnose | 1 | 1991 | 1 | 0.090 |
Why?
|
| Phosphotransferases | 1 | 1991 | 2 | 0.090 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1991 | 2 | 0.090 |
Why?
|
| Salmonella typhimurium | 1 | 1991 | 2 | 0.090 |
Why?
|
| Ethics Committees, Research | 1 | 2011 | 1 | 0.090 |
Why?
|
| Animals | 7 | 2005 | 1369 | 0.090 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 24 | 0.090 |
Why?
|
| Health Services Research | 1 | 2011 | 24 | 0.090 |
Why?
|
| Blotting, Northern | 5 | 2003 | 20 | 0.080 |
Why?
|
| Healthcare Disparities | 1 | 2011 | 69 | 0.080 |
Why?
|
| Molecular Sequence Data | 5 | 2003 | 48 | 0.080 |
Why?
|
| Cloning, Molecular | 2 | 2002 | 6 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2007 | 6 | 0.070 |
Why?
|
| Receptors, CXCR4 | 2 | 2004 | 4 | 0.070 |
Why?
|
| Carcinoma | 1 | 2007 | 11 | 0.070 |
Why?
|
| Mouth | 2 | 2004 | 2 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 2007 | 20 | 0.070 |
Why?
|
| Metallothionein | 2 | 2003 | 4 | 0.060 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2007 | 84 | 0.060 |
Why?
|
| Cell Division | 3 | 2003 | 35 | 0.060 |
Why?
|
| Gingiva | 1 | 2005 | 1 | 0.060 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2005 | 3 | 0.060 |
Why?
|
| Proteins | 1 | 2005 | 32 | 0.060 |
Why?
|
| Cell Line | 3 | 2005 | 82 | 0.060 |
Why?
|
| Apoptosis | 1 | 2005 | 117 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 1997 | 83 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2004 | 70 | 0.050 |
Why?
|
| 3T3 Cells | 2 | 2005 | 12 | 0.050 |
Why?
|
| DNA Primers | 2 | 2004 | 16 | 0.050 |
Why?
|
| Escherichia coli Proteins | 1 | 2003 | 2 | 0.050 |
Why?
|
| Laryngeal Neoplasms | 1 | 2003 | 3 | 0.050 |
Why?
|
| Bacterial Toxins | 1 | 2003 | 5 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2003 | 15 | 0.050 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2003 | 1 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2003 | 3 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2003 | 18 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 26 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2001 | 64 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2002 | 5 | 0.050 |
Why?
|
| Enzymes | 1 | 2002 | 4 | 0.050 |
Why?
|
| Oncogenes | 1 | 2002 | 3 | 0.050 |
Why?
|
| Growth Substances | 1 | 2002 | 8 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2002 | 17 | 0.050 |
Why?
|
| Mutagenesis | 1 | 2001 | 4 | 0.050 |
Why?
|
| DNA Repair | 1 | 2001 | 7 | 0.050 |
Why?
|
| Mice | 2 | 2005 | 555 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2001 | 14 | 0.050 |
Why?
|
| DNA Damage | 1 | 2001 | 15 | 0.050 |
Why?
|
| Plasmids | 3 | 2005 | 10 | 0.040 |
Why?
|
| HIV Infections | 1 | 2003 | 167 | 0.040 |
Why?
|
| RNA | 3 | 2003 | 18 | 0.040 |
Why?
|
| Transcription, Genetic | 3 | 2003 | 28 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 2003 | 5 | 0.040 |
Why?
|
| Amino Acid Sequence | 3 | 2003 | 31 | 0.040 |
Why?
|
| DNA, Viral | 3 | 2004 | 7 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 3 | 2004 | 31 | 0.040 |
Why?
|
| Adenovirus E1A Proteins | 1 | 1999 | 1 | 0.040 |
Why?
|
| Haplorhini | 1 | 1999 | 2 | 0.040 |
Why?
|
| Collagenases | 1 | 1999 | 2 | 0.040 |
Why?
|
| Binding Sites | 1 | 1999 | 16 | 0.040 |
Why?
|
| Protein Binding | 1 | 1999 | 21 | 0.040 |
Why?
|
| Transfection | 3 | 2007 | 33 | 0.040 |
Why?
|
| Flow Cytometry | 3 | 2004 | 41 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2003 | 5 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2004 | 127 | 0.040 |
Why?
|
| Mutation | 2 | 2003 | 51 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 1997 | 16 | 0.030 |
Why?
|
| Colon | 1 | 1997 | 16 | 0.030 |
Why?
|
| Papillomavirus E7 Proteins | 2 | 2007 | 4 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2007 | 12 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2007 | 21 | 0.030 |
Why?
|
| Cell Culture Techniques | 2 | 2005 | 11 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2003 | 98 | 0.030 |
Why?
|
| Female | 3 | 2007 | 2964 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 1992 | 5 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 1991 | 1 | 0.020 |
Why?
|
| Genomic Library | 1 | 1991 | 1 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1991 | 4 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1991 | 9 | 0.020 |
Why?
|
| RNA Splicing | 1 | 1991 | 4 | 0.020 |
Why?
|
| Biological Evolution | 1 | 1991 | 14 | 0.020 |
Why?
|
| Community-Institutional Relations | 1 | 2011 | 17 | 0.020 |
Why?
|
| Helix-Loop-Helix Motifs | 2 | 2003 | 2 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2003 | 9 | 0.020 |
Why?
|
| Rats | 3 | 1997 | 373 | 0.020 |
Why?
|
| Middle Aged | 2 | 2003 | 1544 | 0.020 |
Why?
|
| United States | 1 | 2011 | 764 | 0.020 |
Why?
|
| Chromones | 1 | 2007 | 2 | 0.020 |
Why?
|
| Morpholines | 1 | 2007 | 2 | 0.020 |
Why?
|
| Stilbenes | 1 | 2007 | 2 | 0.020 |
Why?
|
| Anticarcinogenic Agents | 1 | 2007 | 2 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 11 | 0.020 |
Why?
|
| Flavonoids | 1 | 2007 | 5 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 10 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 28 | 0.020 |
Why?
|
| Male | 2 | 2003 | 2620 | 0.020 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2005 | 1 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2005 | 5 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 72 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2003 | 1 | 0.010 |
Why?
|
| Receptors, HIV | 1 | 2003 | 1 | 0.010 |
Why?
|
| Clone Cells | 1 | 2003 | 2 | 0.010 |
Why?
|
| Proviruses | 1 | 2003 | 2 | 0.010 |
Why?
|
| Virus Replication | 1 | 2003 | 6 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 8 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2003 | 8 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2003 | 11 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 8 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2003 | 20 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2003 | 16 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2003 | 33 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2003 | 13 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2003 | 1 | 0.010 |
Why?
|
| Carbon-Oxygen Lyases | 1 | 2003 | 1 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 2 | 0.010 |
Why?
|
| Cricetinae | 1 | 2003 | 6 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2003 | 12 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2003 | 30 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2003 | 39 | 0.010 |
Why?
|
| Disease Progression | 1 | 2003 | 137 | 0.010 |
Why?
|
| Prognosis | 1 | 2003 | 167 | 0.010 |
Why?
|
| Temperature | 1 | 2001 | 3 | 0.010 |
Why?
|
| Cell Death | 1 | 2001 | 6 | 0.010 |
Why?
|
| Protein Transport | 1 | 2001 | 15 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2001 | 1 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2003 | 513 | 0.010 |
Why?
|
| Time Factors | 1 | 2001 | 245 | 0.010 |
Why?
|
| Mammals | 1 | 1997 | 8 | 0.010 |
Why?
|
| Glucagonoma | 1 | 1992 | 1 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1992 | 1 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1992 | 3 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1992 | 5 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1992 | 39 | 0.010 |
Why?
|
| Intestine, Small | 1 | 1992 | 7 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 1992 | 4 | 0.010 |
Why?
|
| Fetus | 1 | 1992 | 114 | 0.010 |
Why?
|
| Cholecystokinin | 1 | 1991 | 3 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1991 | 4 | 0.010 |
Why?
|
| Exons | 1 | 1991 | 6 | 0.010 |
Why?
|
| Glucagon | 1 | 1991 | 5 | 0.010 |
Why?
|
| DNA | 1 | 1991 | 18 | 0.010 |
Why?
|
| Duodenum | 1 | 1991 | 3 | 0.010 |
Why?
|